Women with angina and no obstructive coronary artery disease: IL-6 identifies a cardiometabolic high-risk phenotype and predicts cardiovascular events.
文献摘要
Aims Interleukin-6 (IL-6) has been linked to major adverse cardiovascular events (MACE) in the general population. Among women with angina and no obstructive coronary artery disease (ANOCA), IL-6 has been associated with coronary microvascular dysfunction (CMD), a known driver of risk in this population. We aimed to investigate whether IL-6 identifies a cardiometabolic high-risk phenotype and predicts long-term cardiovascular outcomes in women with ANOCA, and whether its prognostic value is modified by CMD. Methods and results The iPOWER cohort included 1853 women with stable angina and Conclusion IL-6 identifies an inflammation-driven cardiometabolic high-risk phenotype in women with ANOCA and independently predicts MACE. The prognostic value of IL-6 does not depend on CMD, underscoring IL-6 as a clinically relevant marker of long-term cardiovascular risk.